Bicycle Therapeutics (BCYC)
NASDAQ: BCYC
· Real-Time Price · USD
7.45
0.07 (0.95%)
At close: Aug 15, 2025, 3:59 PM
7.36
-1.21%
After-hours: Aug 15, 2025, 04:10 PM EDT
Bicycle Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 19.28M | 25.73M | 35.27M | 36.9M | 39.57M | 41.6M | 26.98M | 24.83M | 22.52M | 15.5M | 14.46M | 15.05M | 16.34M | 13.75M | 11.7M | 11.77M | 11.28M | 11.07M |
Cost of Revenue | 59.91M | 61.55M | 61.57M | 157.09M | 306.5M | 306.51M | 306.42M | 156.22M | 26.03M | 42.67M | 54.6M | 67.1M | 55.81M | 48.85M | 45.05M | 41.21M | 38.45M | 35.07M |
Gross Profit | -38.99M | -34.18M | -26.29M | -120.19M | -266.93M | -264.91M | -279.45M | -131.39M | -3.51M | -27.18M | -40.13M | -52.05M | -39.47M | -35.11M | -33.36M | -29.44M | -27.17M | -24M |
Operating Income | -288.31M | -248.36M | -209.87M | -196.44M | -183.4M | -179.86M | -189.95M | -167.92M | -146.88M | -131.07M | -116.65M | -102.47M | -87M | -76.98M | -65.62M | -64.65M | -61.03M | -56.34M |
Interest Income | 36.77M | 37.07M | 34.28M | 30.26M | 23.66M | 16.7M | 14M | 10.37M | 8.37M | 8.47M | 5.76M | 3.17M | 1.21M | 323K | 120K | 70K | 118K | 466K |
Pretax Income | -248.21M | -208.72M | -173.8M | -169.64M | -163.01M | -166.44M | -179.21M | -160.83M | -141.78M | -125.94M | -114.24M | -102.63M | -89.14M | -79.93M | -68.48M | -67.19M | -62.7M | -56.83M |
Net Income | -242.36M | -203.27M | -169.06M | -166.31M | -165.4M | -168.15M | -180.66M | -161.54M | -139.99M | -124.22M | -112.72M | -100.78M | -87.11M | -78.19M | -66.82M | -66.22M | -61.67M | -55.88M |
Selling & General & Admin | 79.44M | 77.91M | 72.12M | 66.15M | 63.46M | 60.93M | 60.28M | 55.91M | 50.59M | 47.24M | 49.59M | 47.76M | 45.78M | 41.3M | 32.59M | 34.6M | 33.49M | 32.34M |
Research & Development | 228.13M | 204.52M | 195.64M | 190.56M | 182.17M | 174.47M | 156.5M | 136.52M | 119.4M | 99.54M | 81.61M | 69.84M | 57.6M | 49.47M | 44.88M | 41.98M | 38.84M | 35.07M |
Other Expenses | -101.69M | -104.23M | -104.43M | -100.27M | -92.08M | -88.8M | -88.8M | -37.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 205.88M | 178.2M | 163.33M | 156.44M | 153.54M | 146.6M | 127.98M | 154.97M | 169.99M | 146.77M | 131.2M | 117.6M | 103.38M | 90.77M | 77.47M | 76.59M | 72.32M | 67.41M |
Interest Expense | 190K | 960K | 1.73M | 2.5M | 3.28M | 3.28M | 3.26M | 3.27M | 3.27M | 3.33M | 3.34M | 3.34M | 3.34M | 3.28M | 2.98M | 2.6M | 1.78M | 959K |
Selling & Marketing Expenses | -199K | 1.7M | 650.35K | 650.35K | 650.35K | -1.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 307.6M | 281.56M | 252.63M | 241.01M | 230.63M | 222.04M | 217.5M | 193.14M | 169.99M | 146.77M | 131.2M | 117.6M | 103.38M | 90.77M | 77.47M | 76.59M | 72.32M | 67.41M |
Income Tax Expense | -5.85M | -5.5M | -20.1M | -18.7M | -12.98M | -13.61M | 1.46M | 717K | -1.79M | -1.72M | -1.52M | -1.85M | -2.03M | -1.74M | -1.66M | -970K | -1.02M | -957K |
Shares Outstanding (Basic) | 69.25M | 69.2M | 69.05M | 68.99M | 51.99M | 42.56M | 42.42M | 39.58M | 30.19M | 30M | 29.71M | 29.68M | 29.65M | 29.61M | 28.79M | 25.04M | 24.05M | 22.1M |
Shares Outstanding (Diluted) | 69.25M | 69.2M | 69.05M | 68.99M | 51.99M | 42.56M | 42.42M | 39.58M | 30.19M | 30M | 29.71M | 29.68M | 29.65M | 29.61M | 28.79M | 25.04M | 24.05M | 22.1M |
EPS (Basic) | -3.5 | -3.13 | -2.87 | -3.29 | -3.81 | -4.45 | -5.13 | -4.98 | -4.68 | -4.17 | -3.8 | -3.42 | -3.05 | -2.89 | -2.69 | -2.89 | -2.82 | -2.75 |
EPS (Diluted) | -3.5 | -3.13 | -2.87 | -3.29 | -3.81 | -4.45 | -5.13 | -4.98 | -4.68 | -4.17 | -3.8 | -3.42 | -3.05 | -2.89 | -2.69 | -2.89 | -2.82 | -2.75 |
EBITDA | -274.8M | -234.6M | -204.16M | -190.96M | -178.86M | -183.1M | -183.59M | -161.64M | -141.03M | -126.25M | -112.96M | -99.76M | -85.22M | -75.42M | -64.19M | -63.3M | -59.69M | -54.74M |
EBIT | -272.09M | -211.24M | -154.84M | -141.41M | -128.81M | -153.64M | -187.02M | -162.35M | -139.32M | -123.51M | -111.65M | -100.04M | -86.54M | -76.5M | -65.5M | -63.91M | -60.24M | -55.2M |
Depreciation & Amortization | -2.72M | -2.77M | 7.2M | 7.15M | 6.64M | 6.65M | 6.57M | 6.31M | 5.87M | 4.83M | 3.68M | 2.69M | 1.77M | 1.5M | 1.41M | 1.33M | 1.33M | 1.3M |